STAGE III NSCLC

Clinical trials for STAGE III NSCLC explained in plain language.

Never miss a new study

Get alerted when new STAGE III NSCLC trials appear

Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug shrinks lung tumors before surgery in early trial

Disease control Ongoing

This study tests whether the drug lorlatinib can shrink tumors in people with a specific type of stage III lung cancer (ALK-positive) before they have surgery. About 48 adults will take lorlatinib for a set time, then doctors will check if the tumor is gone or much smaller. The g…

Matched conditions: STAGE III NSCLC

Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control

Last updated May 17, 2026 08:02 UTC

STAGE III NSCLC

Get alerted when new STAGE III NSCLC trials appear

New drug shrinks lung tumors before surgery in early trial